P A Lachenbruch1, W Rida, J Kou
1U.S. FDA/Center for Biologics Evaluation and Research, Rockville, Maryland 20852, USA. lachenbruch@cber.fda.gov
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Demonstrating vaccine manufacturing consistency requires assessing multigroup equivalence. A new similarity test offers a robust alternative to standard methods, especially for non-normally distributed data.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: